Dr Lothar
Krinke

Lothar has been the CEO of the Magstim Group since May 2017, a company that was formed through the merger of Magstim Ltd. and Technomed Medical Accessories.  He is responsible for establishing and executing the growth strategy for the transcranial magnetic stimulation and intra-operative nerve monitoring businesses globally.

Since 2018 he holds an Adjunct Assistant Professor position in Neuroscience at the West Virginia University.

Lothar was named Vice President & General Manager of the Medtronic Brain Modulation (DBS) business in May 2011.  Responsibilities included establishing and executing a comprehensive, global business strategy for the DBS Therapies.  In a prior role as Vice President, Research and Business Development at Medtronic Neuromodulation he was responsible for managing internal and external research programs. Krinke’s group managed drug infusion therapy programs funded by the Ventures Organization as well as Business Development and IP.  Prior to joining Medtronic in 2004 as Senior Director, Bioscience Technology Development, he served as Vice President for Business Development and Executive Team member of Endogeny Bio Corporation, a biotechnology startup company.  Krinke has over 10 years of biomedical strategy expertise from top management consulting firms.  He has been an American Cancer Society Fellow at the California Institute of Technology and holds a Ph.D. in Molecular Biology from the University at Albany.  Dr. Krinke received his undergraduate education at the Technische Universität Braunschweig in Germany.  He is the recipient of the Rumbough Award for Dedication to and Achievements in Diabetes research from the Juvenile Diabetes Research Foundation International.  He is a board member of the Brain Mapping Medical Research Organisation – UCLA.